Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach

Background and Aim. Cholangiocarcinoma (CCA) is the most frequent biliary malignancy, which poses high mortality rate due to lack of early detection. Hence, most CCA cases are present at the advanced to late stages with local or distant metastasis at the time of diagnosis. Currently available tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Janvilisri, Tavan, Leelawat, Kawin, Roytrakul, Sittiruk, Paemanee, Atchara, Tohtong, Rutaiwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427802/
https://www.ncbi.nlm.nih.gov/pubmed/26060332
http://dx.doi.org/10.1155/2015/105358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427802/
https://www.ncbi.nlm.nih.gov/pubmed/26060332
http://dx.doi.org/10.1155/2015/105358

Ejemplares similares